Local view for "http://purl.org/linkedpolitics/eu/plenary/2004-02-10-Speech-2-222"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20040210.10.2-222"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spoken text |
".
The EU drugs strategy 2000-2004 provides a framework for a balanced and integrated approach on all drug-related activities in the European Union. It has also been endorsed by the new Member States and the candidate countries who have, in the meantime, set up national drug strategies and improved their capacities for taking action against drugs with the support of the Phare Programme. The Union also has a number of drug action plans involving certain regions either producing or serving as transit countries for drugs, such as Latin America, Central Asia and the Balkans.
Research shows that a link between a particular drug policy line and the drug situation is difficult to establish. The availability and careful evaluation of relevant and reliable information are undoubtedly key elements in developing an evidence-based drug policy. The work of the European Monitoring Centre on Drugs and Drug Addiction and the work of Europol in this area form part of the basis for the Commission communication to the Council and the European Parliament on the mid-term evaluation of the EU Action Plan on Drugs. This mid-term evaluation was a first step in a larger process. By the end of this year we will have the final evaluation. Without wanting to pre-empt the results of the final evaluation, the following developments on the EU drugs market can already be observed.
Heroin seizures have increased since 2001. Our assessment is that street prices are generally stable or even decreasing. The number of heroin addicts seems to be relatively stable in the European Union, although there are marked differences between the Member States. Cannabis remains the most widely-used illicit drug and its use is still increasing in many Member States. The use of synthetic drugs such as ecstasy and the use of cocaine seem to be increasing in certain population groups, although the use of these drugs among the general population remains low."@en1
|
| lpv:unclassifiedMetadata |
Named graphs describing this resource:
The resource appears as object in 2 triples